153 related articles for article (PubMed ID: 36375315)
1. Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation.
Jyothula SSK; Peters A; Liang Y; Bi W; Shivshankar P; Yau S; Garcha PS; Yuan X; Akkanti B; Collum S; Wareing N; Thandavarayan RA; Poli de Frias F; Rosas IO; Zhao B; Buja LM; Eltzschig HK; Huang HJ; Karmouty-Quintana H
EBioMedicine; 2022 Dec; 86():104351. PubMed ID: 36375315
[TBL] [Abstract][Full Text] [Related]
2. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
EBioMedicine; 2022 Aug; 82():104185. PubMed ID: 35870428
[TBL] [Abstract][Full Text] [Related]
4. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
Liu G; Friggeri A; Yang Y; Milosevic J; Ding Q; Thannickal VJ; Kaminski N; Abraham E
J Exp Med; 2010 Aug; 207(8):1589-97. PubMed ID: 20643828
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.
Sinha S; Castillo V; Espinoza CR; Tindle C; Fonseca AG; Dan JM; Katkar GD; Das S; Sahoo D; Ghosh P
bioRxiv; 2022 Jul; ():. PubMed ID: 34873597
[TBL] [Abstract][Full Text] [Related]
6. The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis.
Wu S; Liu M; Zhang M; Ye X; Gu H; Jiang C; Zhu H; Ye X; Li Q; Huang X; Cao M
Front Immunol; 2024; 15():1275064. PubMed ID: 38370408
[TBL] [Abstract][Full Text] [Related]
7. CTHRC1: An Emerging Hallmark of Pathogenic Fibroblasts in Lung Fibrosis.
Mukhatayev Z; Adilbayeva A; Kunz J
Cells; 2024 May; 13(11):. PubMed ID: 38891078
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
9. Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function.
Binks AP; Beyer M; Miller R; LeClair RJ
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292882
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane protease, serine 4 (TMPRSS4) is upregulated in IPF lungs and increases the fibrotic response in bleomycin-induced lung injury.
Valero-Jiménez A; Zúñiga J; Cisneros J; Becerril C; Salgado A; Checa M; Buendía-Roldán I; Mendoza-Milla C; Gaxiola M; Pardo A; Selman M
PLoS One; 2018; 13(3):e0192963. PubMed ID: 29529050
[TBL] [Abstract][Full Text] [Related]
11. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
12. Collagen 3D matrices as a model for the study of cell behavior in pulmonary fibrosis.
Machahua C; Vicens-Zygmunt V; Ríos-Martín J; Llatjós R; Escobar-Campuzano I; Molina-Molina M; Montes-Worboys A
Exp Lung Res; 2022 Apr; 48(3):126-136. PubMed ID: 35594338
[No Abstract] [Full Text] [Related]
13. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
[TBL] [Abstract][Full Text] [Related]
14. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.
Naik PK; Bozyk PD; Bentley JK; Popova AP; Birch CM; Wilke CA; Fry CD; White ES; Sisson TH; Tayob N; Carnemolla B; Orecchia P; Flaherty KR; Hershenson MB; Murray S; Martinez FJ; Moore BB;
Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(12):L1046-56. PubMed ID: 23043074
[TBL] [Abstract][Full Text] [Related]
15. Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis.
Tsukui T; Sun KH; Wetter JB; Wilson-Kanamori JR; Hazelwood LA; Henderson NC; Adams TS; Schupp JC; Poli SD; Rosas IO; Kaminski N; Matthay MA; Wolters PJ; Sheppard D
Nat Commun; 2020 Apr; 11(1):1920. PubMed ID: 32317643
[TBL] [Abstract][Full Text] [Related]
16. Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Llatjos R; Escobar I; Dorca J; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2016 Nov; 17(1):144. PubMed ID: 27816054
[TBL] [Abstract][Full Text] [Related]
17. Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis.
MacKenzie B; Korfei M; Henneke I; Sibinska Z; Tian X; Hezel S; Dilai S; Wasnick R; Schneider B; Wilhelm J; El Agha E; Klepetko W; Seeger W; Schermuly R; Günther A; Bellusci S
Respir Res; 2015 Jul; 16(1):83. PubMed ID: 26138239
[TBL] [Abstract][Full Text] [Related]
18. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
19. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
20. The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution.
de Rooij LPMH; Becker LM; Teuwen LA; Boeckx B; Jansen S; Feys S; Verleden S; Liesenborghs L; Stalder AK; Libbrecht S; Van Buyten T; Philips G; Subramanian A; Dumas SJ; Meta E; Borri M; Sokol L; Dendooven A; Truong AK; Gunst J; Van Mol P; Haslbauer JD; Rohlenova K; Menter T; Boudewijns R; Geldhof V; Vinckier S; Amersfoort J; Wuyts W; Van Raemdonck D; Jacobs W; Ceulemans LJ; Weynand B; Thienpont B; Lammens M; Kuehnel M; Eelen G; Dewerchin M; Schoonjans L; Jonigk D; van Dorpe J; Tzankov A; Wauters E; Mazzone M; Neyts J; Wauters J; Lambrechts D; Carmeliet P
Cardiovasc Res; 2023 Mar; 119(2):520-535. PubMed ID: 35998078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
